ArticleOncogene2018

The novel BET bromodomain inhibitor BI 894999 represses super-enhancer-associated transcription and synergizes with CDK9 inhibition in AML.

Daniel Gerlach et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.